AI
Neutral signalScored 2026-10-19 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
C3.ai, Inc.
- Nom
- C3.ai, Inc.
- Secteur
- Technology
- Industrie
- Software - Application
- Bourse
- NYSE
- Capitalisation
- $1.9B
- Employés
- 764
- PDG
- Thomas Siebel
- Site web
- https://www.C3.ai
- Marché
- ASGNBBAICLVTCNXCDXCFORTY
C3.ai, Inc. is a leading provider of enterprise artificial intelligence (AI) software solutions, serving a global clientele across North America, Europe, the Middle East, Africa, and the Asia Pacific region. Its core offerings include the C3 AI Application Platform, a robust environment for developing, deploying, and operating enterprise-scale AI applications. Complementing this platform are specialized tools such as C3 AI Ex Machina for preparing data for analysis, C3 AI CRM which is tailored for specific industry customer relationship management needs, and C3 AI Data Vision for insightful visualization and understanding of complex data relationships. Furthermore, C3.ai delivers a comprehensive portfolio of pre-built, industry-specific AI applications designed to tackle critical business challenges. These include solutions for optimizing inventory levels (C3 AI Inventory Optimization), mitigating supply chain disruptions (C3 AI Supply Network Risk), proactively managing customer attrition (C3 AI Customer Churn Management), streamlining production schedules (C3 AI Production Schedule Optimization), forecasting equipment failures (C3 AI Predictive Maintenance), identifying financial irregularities (C3 AI Fraud Detection), and optimizing energy consumption (C3 AI Energy Management). These integrated, turnkey AI applications cater to a wide array of market segments, including oil and gas, chemicals, utilities, manufacturing, financial services, defense, intelligence, aerospace, healthcare, and telecommunications. The company maintains strategic alliances with key players like Baker Hughes (for oil & gas), FIS (financial services), Raytheon, and major technology firms including AWS, Intel, Google, and Microsoft. Originally incorporated in 2009 as C3 IoT, Inc., the company adopted its current name, C3.ai, Inc., in June 2019 and is headquartered in Redwood City, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 902 391 titres (~10 169 527,48 $ US)
- Insiders
- SIEBEL THOMAS M
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$17,116,707
Avg sell (VWAP, 90d window) $10.88 vs last close $11.69 (+7.4%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$15,140,701 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-10-13
- Liquidity
- Liquid $58,599,462/day · 20d vol
- Last synced
-
2026-10-20 21:10:05
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-13 | SIEBEL THOMAS M | Sell · S · 10b5-1 | 435,363 | $11.82 | $5,145,076 | Form 4 |
| 2026-10-12 | Lath Hitesh | Sell · S · 10b5-1 | 20,000 | $12.37 | $247,400 | Form 4 |
| 2026-09-16 | Lath Hitesh | Sell · S | 21,077 | $10.48 | $220,887 | Form 4 |
| 2026-09-16 | SIEBEL THOMAS M | Sell · S · 10b5-1 | 162,247 | $10.54 | $1,710,083 | Form 4 |
| 2026-09-15 | SIEBEL THOMAS M | Sell · S · 10b5-1 | 282,001 | $10.90 | $3,073,811 | Form 4 |
| 2026-09-14 | SIEBEL THOMAS M | Sell · S | 22,780 | $10.56 | $240,557 | Form 4 |
| 2026-09-02 | SIEBEL THOMAS M | Sell · S | 16,890 | $10.30 | $173,967 | Form 4 |
| 2026-08-11 | SIEBEL THOMAS M | Sell · S · 10b5-1 | 453,314 | $10.51 | $4,764,330 | Form 4 |
| 2026-08-04 | Lath Hitesh | Sell · S · 10b5-1 | 20,000 | $10.00 | $200,000 | Form 4 |
| 2026-08-03 | SIEBEL THOMAS M | Sell · S | 139,500 | $9.61 | $1,340,595 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2023-09-05 | Pete Sessions | Sale (Full) | $15,001 - $50,000 |
| 2021-06-09 | Thomas Suozzi | Sale (Full) | $15,001 - $50,000 |
| 2021-06-03 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2021-05-07 | Frederick Stephen Upton | Purchase | $15,001 - $50,000 |
| 2021-05-05 | Thomas Suozzi | Sale (Full) | $50,001 - $100,000 |
| 2021-04-19 | Pete Sessions | Purchase | $1,001 - $15,000 |
| 2021-04-07 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2021-03-15 | Thomas Suozzi | Purchase | $1,001 - $15,000 |
| 2021-03-04 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2021-03-04 | Tom Malinowski | Purchase | $15,001 - $50,000 |
| 2021-03-01 | Thomas Suozzi | Purchase | $15,001 - $50,000 |
| 2021-01-26 | Tom Malinowski | Sale (Full) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-19 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
C3.ai (AI) presents a deeply concerning financial profile with net margins at -188%, severe cash burn, and no identifiable near-term catalysts to reverse the trajectory.
The first sentence of the analysis written for AI on 2026-10-19 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Supports a bullish reading. Interesting trend — weekly bias up
- Financial indicators Unavailable or mixed. Current ratio 6.64 · operating margin -195% — readings disagree
Suggested stop 10.60, nearest stored support minus 0.5 ATR(9.3% under the last close). Reward/risk to the next stored resistance is 0.34. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-16 C3.ai, Inc. (AI) Dips More Than Broader Market: What You Should Know C3.ai, Inc. (AI) concluded the recent trading session at $11.33, signifying a -6.83% move from its prior day''s close.
- 2026-10-16 AI ''espionage'' is a reality that companies need to be ''wary of,'' Jay Clayton says U.S. companies and the Trump administration both "need to be wary" of AI-related foreign espionage attempts, Director of National Intelligence Jay Clayton told CNBC. Clayton was asked how concerned Americans should be in light of the recently revealed case charging Saudi national Abdulrahman Alfozan with installing a recording device in an OpenAI conference room.
- 2026-10-15 Insperity Unveils Its AI Capabilities for the Future of HR Highlighting New Insperity HR360 AI Agent As organizations navigate a workplace increasingly shaped by artificial intelligence (AI), [url="]Insperity, Inc.[/url] (NYSE: NSP), a leading provider of human
- 2026-10-15 bioAffinity Technologies to Present New Perspectives on CyPath® Lung''s Use for Cancer Risk Assessment at CHEST 2026 [url="]bioAffinity Technologies, Inc.[/url] (Nasdaq: BIAF; BIAFW),a biotechnology company developing noninvasive healthcare solutions for the early detection an
- 2026-10-13 C3.ai, Inc. (AI) is Attracting Investor Attention: Here is What You Should Know C3.ai (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 2026-10-13 bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026 [url="]bioAffinity Technologies[/url], Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company developing noninvasive healthcare solutions for the early detection an
- 2026-10-12 AI, Bond Yields, Cyber Top IMF Risks to Global Financial Markets Rising fiscal deficits could make it harder for governments to meet their financial obligations and handle risks of the future.
- 2026-10-12 C3.ai vs. UiPath: Which AI-Driven Tech Stock Is a Better Buy in 2026? C3.ai is transitioning its business model toward consumption-based pricing to expand its reach among mid-sized enterprise customers. UiPath achieved positive net income in fiscal 2026 while continuing to scale its AI-driven automation platform for global organizations.
- 2026-10-12 Northland analyst says it''s time to hop back into C3.ai stock C3.ai Inc (AI) stock is pushing higher on Monday morning after Northland Capital issued a bullish note in favour of the enterprise artificial intelligence software company. In his research note, analyst Mike Latimore upgraded AI to Outperform, and raised his price target to $16, indicating potential upside of more than 40% from its previous close.
- 2026-10-12 SoundHound AI Slides 5% to Fresh Lows While C3.ai Climbs 4% on Northland Upgrade; UiPath Slips Agentic software names are splitting apart, and the gap says a lot about how the market grades this group. SoundHound AI (NASDAQ:SOUN) stock is at $5.14, down 5% early in the session and sitting at fresh lows.
Market snapshot
Financial ratios
| Metric | Trend | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 30.9% | 60.6% | 57.5% | 67.6% | 74.8% | |
| Ebit Margin | -187.6% | -74.0% | -89.8% | -100.5% | -75.7% | |
| Ebitda Margin | -182.2% | -70.7% | -85.7% | -98.2% | -73.6% | |
| Operating Profit Margin | -194.9% | -83.4% | -102.5% | -108.9% | -77.6% | |
| Pretax Profit Margin | -187.6% | -74.0% | -89.8% | -100.5% | -75.7% | |
| Continuous Operations Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Net Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Bottom Line Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Current Ratio | 6.643 | 6.856 | 8.838 | 6.534 | 7.062 | |
| Quick Ratio | 6.643 | 6.856 | 8.838 | 6.534 | 7.167 | |
| Solvency Ratio | -2.811 | -1.472 | -1.619 | -1.516 | -1.030 | |
| Cash Ratio | 0.621 | 1.246 | 1.633 | 2.094 | 2.261 | |
| Price To Earnings Ratio | -2.636 | -9.826 | -9.628 | -7.604 | -9.234 | |
| Price To Earnings Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Forward Price To Earnings Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Price To Earnings Diluted Ratio | -2.636 | -9.826 | -9.628 | -7.604 | -9.234 | |
| Price To Earnings Diluted Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Price To Book Ratio | 1.898 | 3.389 | 3.079 | 2.201 | 1.793 | |
| Price To Sales Ratio | 4.958 | 7.303 | 8.659 | 7.671 | 7.018 | |
| Price To Free Cash Flow Ratio | -6.506 | -63.926 | -29.759 | -10.932 | -19.546 | |
| Price To Operating Cash Flow Ratio | -6.572 | -68.618 | -43.123 | -17.690 | -20.516 | |
| Debt To Assets Ratio | 0.007 | 0.005 | 0.003 | 0.002 | 0.003 | |
| Debt To Equity Ratio | 0.009 | 0.006 | 0.004 | 0.003 | 0.004 | |
| Debt To Capital Ratio | 0.008 | 0.006 | 0.004 | 0.003 | 0.004 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.249 | 1.224 | 1.189 | 1.186 | 1.183 | |
| Working Capital Turnover Ratio | 0.364 | 0.494 | 0.399 | 0.321 | 0.258 | |
| Operating Cash Flow Ratio | -1.771 | -0.314 | -0.609 | -0.850 | -0.576 | |
| Operating Cash Flow Sales Ratio | -0.754 | -0.106 | -0.201 | -0.434 | -0.342 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.010 | 1.073 | 1.449 | 1.618 | 1.050 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -33.851 | -8.635 | -19.331 | -49.462 | -23.931 | |
| Capital Expenditure Coverage Ratio | -98.944 | -13.625 | -2.227 | -1.618 | -20.150 | |
| Dividend Paid And Capex Coverage Ratio | -98.944 | -13.625 | -2.227 | -1.618 | -20.150 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -2.588 | -9.747 | -9.487 | -6.731 | -7.727 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 30.9% | ▼-29.7% | ▼-27.4% |
| Ebit Margin | -187.6% | ▼-113.7% | ▼-82.1% |
| Ebitda Margin | -182.2% | ▼-111.5% | ▼-80.1% |
| Operating Profit Margin | -194.9% | ▼-111.5% | ▼-81.4% |
| Pretax Profit Margin | -187.6% | ▼-113.7% | ▼-82.1% |
| Continuous Operations Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Net Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Bottom Line Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Current Ratio | 6.643 | ▼-0.213 | ▼-0.543 |
| Quick Ratio | 6.643 | ▼-0.213 | ▼-0.565 |
| Solvency Ratio | -2.811 | ▼-1.339 | ▼-1.121 |
| Cash Ratio | 0.621 | ▼-0.625 | ▼-0.950 |
| Price To Earnings Ratio | -2.636 | ▲7.190 | ▲5.150 |
| Price To Earnings Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Forward Price To Earnings Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Price To Earnings Diluted Ratio | -2.636 | ▲7.190 | ▲5.150 |
| Price To Earnings Diluted Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Price To Book Ratio | 1.898 | ▼-1.491 | ▼-0.574 |
| Price To Sales Ratio | 4.958 | ▼-2.345 | ▼-2.164 |
| Price To Free Cash Flow Ratio | -6.506 | ▲57.419 | ▲19.627 |
| Price To Operating Cash Flow Ratio | -6.572 | ▲62.045 | ▲24.731 |
| Debt To Assets Ratio | 0.007 | ▲0.002 | ▲0.003 |
| Debt To Equity Ratio | 0.009 | ▲0.003 | ▲0.004 |
| Debt To Capital Ratio | 0.009 | ▲0.003 | ▲0.004 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.249 | ▲0.025 | ▲0.042 |
| Working Capital Turnover Ratio | 0.364 | ▼-0.130 | ▼-0.003 |
| Operating Cash Flow Ratio | -1.771 | ▼-1.458 | ▼-0.947 |
| Operating Cash Flow Sales Ratio | -0.754 | ▼-0.648 | ▼-0.387 |
| Free Cash Flow Operating Cash Flow Ratio | 1.010 | ▼-0.063 | ▼-0.230 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | -33.851 | ▼-25.215 | ▼-6.809 |
| Capital Expenditure Coverage Ratio | -98.944 | ▼-85.319 | ▼-71.631 |
| Dividend Paid And Capex Coverage Ratio | -98.944 | ▼-85.319 | ▼-71.631 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -2.588 | ▲7.159 | ▲4.668 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $1.24B | $2.84B | $2.69B | $2.05B | $1.77B | |
| Enterprise value | $1.18B | $2.68B | $2.53B | $1.76B | $1.44B | |
| EV / Sales | 4.71x | 6.89x | 8.13x | 6.61x | 5.69x | |
| EV / Op. cash flow | -6.25x | -64.76x | -40.49x | -15.25x | -16.63x | |
| EV / Free cash flow | -6.19x | -60.34x | -27.95x | -9.42x | -15.84x | |
| EV / EBITDA | -2.59x | -9.75x | -9.49x | -6.73x | -7.73x | |
| Net debt / EBITDA | 0.13x | 0.58x | 0.62x | 1.08x | 1.80x | |
| Current ratio | 6.64x | 6.86x | 8.84x | 6.53x | 7.06x | |
| Income quality | 0.40x | 0.14x | 0.22x | 0.43x | 0.45x | |
| Graham net-net | $3 | $5 | $6 | $6 | $8 | |
| Tax burden | 100.2% | 100.3% | 100.3% | 100.3% | 100.4% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $601.4M | $772.4M | $802.1M | $752.8M | $910.3M | |
| Invested capital | $668.9M | $852.3M | $891.3M | $838.0M | $925.4M | |
| Return on assets | -57.6% | -28.1% | -26.9% | -24.4% | -16.4% | |
| Operating ROA | -52.9% | -31.4% | -29.7% | -25.6% | -16.6% | |
| Return on tangible assets | -57.7% | -28.2% | -27.0% | -24.4% | -16.4% | |
| Return on equity | -71.9% | -34.4% | -32.0% | -28.9% | -19.4% | |
| Return on invested capital | -68.2% | -36.1% | -33.9% | -30.0% | -19.1% | |
| Return on capital employed | -68.7% | -36.3% | -34.0% | -30.0% | -19.2% | |
| Earnings yield | -37.9% | -10.2% | -10.4% | -13.1% | -10.8% | |
| Free cash flow yield | -15.4% | -1.6% | -3.4% | -9.1% | -5.1% | |
| Capex / Op. cash flow | -1.0% | -7.3% | -44.9% | -61.8% | -5.0% | |
| Capex / Depreciation | 14.1% | 24.1% | 220.2% | 1174.7% | 82.7% | |
| Capex / Sales | 0.8% | 0.8% | 9.0% | 26.8% | 1.7% | |
| SG&A / Sales | 134.2% | 85.8% | 95.2% | 97.6% | 92.8% | |
| R&D / Sales | 91.5% | 58.2% | 64.8% | 79.0% | 59.6% | |
| Stock comp / Sales | 0.0% | 59.4% | 69.5% | 81.2% | 44.9% | |
| Intangibles / Total assets | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| Days sales outstanding | 147d | 129d | 153d | 184d | 116d | |
| Days payables outstanding | 12d | 36d | 31d | 104d | 311d | |
| Operating cycle | 147d | 129d | 153d | 184d | 25d | |
| Cash conversion cycle | 135d | 93d | 122d | 80d | -286d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years